期刊文献+

福辛普利和非络地平逆转原发性高血压左室肥厚的对比研究 被引量:1

Comparative study on Fosinoprill and Felodipine converting left ventricular myocardial hypertrophy in essential hypentensive patients
下载PDF
导出
摘要 目的 :对比研究福辛普利和非络地平逆转原发性高血压 (EH)左室肥厚的作用。方法 :将 10 4例EH伴左室肥厚的患者随机分为福辛普利组和非络地平组 ,于服药前及服药后 6个月、12个月、2 4个月分别测定左室舒张末内径 (LVDT)、舒张期室间隔厚度 (IVST)、左室后壁厚度 (LVPWT)、左室射血分数 (LVEF)、心排量 (CO)、A峰 /E峰比值 (A/E比值 )。结果 :两组治疗前后比较LVEF、CO均无变化 ,而A/E比值则明显降低 ;左室重量指数 (LVMI)、LVDd、IVST、LVPDWT在福辛普利组明显下降 ,而在非络地平组则无变化。结论 :福辛普利和非络地平均能明显改善左室舒张功能 ,但福辛普利能明显减轻左室肥厚。 Objective To observe the effects of conversal of Fosinoprill and Felodipine on left ventricular myocardial hypertrophy in essential hypertension(EH).Methods 104 EH patients with ventricular myocardial hypertrophy were randomly divided into Fosinoprill group and Felodipine group.Before administration and at 6th month 12th month and 24th month after administration,we measured respectively left ventricular diastolic diameter(LVDd),interventricular septal thick(IVST),left ventricular posterior wall thick(LVPWT),left ventricular ejection fraction(LVEF),cardiac output(CO)and A peak/E peak ratio(A/E ratio).Results Before and after treatment,LVEF and CO of two groups did not change.But A/E ratio of two groups was significantly decreased.Left ventricular mass index(LVMI),LVDd,IVST and LVPWT were decreased remarkably in Fosinoprill group.But they did not change significantly in Felodipine group. Conclusions Fosinoprill and Felodipine may improve left ventricular diastolic function.Only Fosinoprill may significantly reduce left ventricular myocardial hypertrophy.
出处 《河南诊断与治疗杂志》 2002年第4期239-240,共2页 Henan Journal of Diagnosis and Therapy
关键词 原发性高血压 左心室肥厚 福辛普利 非络地平 EH LVH Hypertensoin left ventricular myocardial hypertrophy Fosinoprill Felodipine
  • 相关文献

参考文献1

二级参考文献7

  • 1Chalmers J,et al.WHO-ISH Hypertension Guidelines Committee.1999World Health Organization-International Society of Hypertension GuidelinesfortheManagementof Hypertension[].Journal of Hypertension.1999
  • 2Staessen JA,Fagard RH,Lijnen PJ,et al.Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies[].The American Journal of Cardiology.1991
  • 3Devereux RB.Detection of left ventricular hypertrophy by Mmode echocardiography, anatomic validation, standardization, and comparison to other methods[].Journal of Hypertension.1987
  • 4Teichholz LE,Kreulen FT,Herman FMV,et al.Problems in echocardio-graphy volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy[].The American Journal of Cardiology.1996
  • 5Mackay JH,Arcuri KE,Goldberg AI,et al.Losartan and low dose hydrochlorothiazide in patients with essential hypertension[].Archives of Internal Medicine.1996
  • 6Cottone S,Vadala A,Vella MC,et al.Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension[].American Journal of Hypertension.1998
  • 7Gottdiener JS,Reda DJ,Massie BM,et al.Effect of single drug therapy on reduction of left ventricularmass in m ild to moderate hypertension: comparison of six antihypertensive agents[].Circulation.1997

共引文献13

同被引文献18

  • 1咪达普利临床试验协作组,刘金来,陈璘,彭朝权,赵长林,陈鲁原,蒋祖勋,孟素荣,侯玉清,熊龙根.咪达普利与福辛普利治疗原发性高血压患者咳嗽发生率及降压疗效的对照研究[J].循证医学,2005,5(6):350-353. 被引量:1
  • 2谢幼娟.补肾养阴活血汤治疗更年期高血压40例临床观察[J].中外健康文摘,2012,9(26):236-237.
  • 3Chrysanthos Z, Asterios K, Anna GP, et al., Effects of fosinopril on renal function in patients with mild to moder- ate essential hypertension[J]. Clinical Drug Investigati- on, 1996,12(5) :251.
  • 4Beaulieu M, Nadeau A, Lacourciere Y, et al. Post-exerc- ise reduction in blood pressure in hypertensive subjects: effects of angiotensin converting enzyme inhibition[J]. Br J Clin Pharmacol, 1993,36(4) : 331.
  • 5Neville F, Fulmor IE, Nidhola PS, et al. Fosinopril mon- otherapy: relationship between blood pressure reduction and time of administration[J]. Clin Cardiol, 1993,16(4) : 324.
  • 6Robert J, Duchin KL, Gore RD, et al. Once-daily fosino-pril in the treatment of hypertension[J]. Hypertension, 1991,17(5): 636.
  • 7Keilani T, Schlueter WA, Levin ML, et al. Improvement of lipid abnormalities associated with proteinuria using fo- sinopril, an angiotensin-converting enzyme inhibitor[J]. Ann lntern Med, 1993,118(4) : 246.
  • 8Bilge AK, Atilgan D, Tukek T, et al. Effects of amlodip- ine and fosinopril on heart rate variability and left ventric- ular mass in mild-to-moderate essential hypertension[J]. Int J Clin Pract, 2005,59(3) :306.
  • 9Francesco P, Puglese F, Marcantonio AM, et al. Evalua- tion of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring[J]. Clin Cardi- ol, 1995,18(7): 401.
  • 10Cremonesi G, Cavalieri L, Cikes I, et al. Fixed combina- tions of delapril plus indapamide vs fosinopril plus hydro- hlorothiazide in mild to moderate essential hypertension [J].Adv Ther, 2002,19(3): 129.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部